Cortical inhibitory neurons and schizophrenia

Nature Reviews Neuroscience

Volumn 6, Issue 4, 2005, Pages 312-324

  Lewis, David A ^a   Hashimoto, Takanori ^a   Volk, David W ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; PARVALBUMIN;

BRAIN CELL; CELL SUBPOPULATION; COGNITION; COGNITIVE DEFECT; CORTICAL SYNCHRONIZATION; GABAERGIC SYSTEM; HUMAN; NONHUMAN; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNTHESIS; WORKING MEMORY;

ANIMALS; CEREBRAL CORTEX; HUMANS; NERVE NET; NEURAL INHIBITION; NEURONS; SCHIZOPHRENIA;

EID: 16344372645     PISSN: 1471003X     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn1648     Document Type: Review

References (119)

1. Lewis, D. A. & Lieberman, J. A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325-334 (2000).
2. Gottesman I. I. Schizophrenia Genesis: The Origins of Madness (Freeman, New York, 1991).
3. Owen, M. J., Williams, N. M. & O'Donovan, M. C. The molecular genetics of schizophrenia: new findings promise new insights. Mol. Psychiatry 9, 14-27 (2004).
4. Lewis, D. A. & Levitt, P. Schizophrenia as a disorder of neurodevelopment. Annu. Rev. Neurosci. 25, 409-432 (2002).
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th edn (American Psychiatry Association, Washington, D.C., 1994).
6. Elvevåg, B. & Goldberg, T. E. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14, 1-21 (2000).
7. Davidson, M. et al. Behavioral and intellectual markers for schizophrenia in apparently healthy male adolescents. Am. J. Psychiatry 156, 1328-1335 (1999).
8. Saykin, A. J. et al. Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Arch. Gen. Psychiatry 51, 124-131 (1994).
9. Sitskoorn, M. M., Aleman, A., Ebisch, S. J., Appels, M. C. & Kahn, R. S. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr. Res. 71, 285-295 (2004).
10. Green, M. F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153, 321-330 (1996). This review showed the central importance of cognitive deficits in long-term functional outcome in inidividuals with schizophrenia.
11. Blum, B. P. & Mann, J. J. The GABAergic system in schizophrenia. Int. J. Neuropsychopharmacol. 5, 159-179 (2002).
12. Benes, F. M. & Berretta, S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25, 1-27 (2001).
13. Miller, E. K. & Cohen, J. D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 24, 167-202 (2001).
14. Weinberger, D. R., Berman, K. F. & Zec, R. F. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch. Gen. Psychiatry 43, 114-124 (1986). This seminal investigation showed that dysfunction of the prefrontal cortex, as reflected in reduced cerebral blood flow, was prominent when individuals with schizophrenia were asked to perform certain cognitive tasks.
15. Perlstein, W. M., Carter, C. S., Noll, D. C. & Cohen, J. D. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am. J. Psychiatry 158, 1105-1113 (2001).
16. Callicott, J. H. et al. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am. J. Psychiatry 160, 2209-2215 (2003).
17. MacDonald, A. W. et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in a never medicated first-episode psychotic sample. Am. J. Psychiatry (in the press).
18. Barch, D. M., Sheline, Y. I., Csernansky, J. G. & Snyder, A. Z. Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol. Psychiatry 53, 376-384 (2003).
19. Silver, H., Feldman, P., Bilker, W. & Gur, R. C. Working memory deficit as a core neuropsychological dysfunction in schizophrenia. Am. J. Psychiatry 160, 1809-1816 (2003).
20. Goldman-Rakic, P. S. Topography of cognition: parallel distributed networks in primate association cortex. Annu. Rev. Neurosci. 11, 137-156 (1988).
21. Goldman-Rakic, P. S. Cellular basis of working memory. Neuron 14, 477-485 (1995). This review clearly summarizes the role of the coordinated, sustained firing of prefrontal pyramidal neurons in working memory.
22. Wilson, F. A., O'Scalaidhe, S. P. & Goldman-Rakic, P. S. Functional synergism between putative γ-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex. Proc. Natl Acad. Sci. USA 91, 4009-4013 (1994).
23. A blockade of prefrontal cortical neurons engaged by working memory. J. Neurosci. 20, 485-494 (2000).
24. Sawaguchi, T., Matsumura, M. & Kubota, K. Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys. Exp. Brain Res. 75, 457-469 (1989).
25. Constantinidis, C., Williams, G. V. & Goldman-Rakic, P. S. A role for inhibition in shaping the temporal flow of information in prefrontal cortex. Nature Neurosci. 5, 175-180 (2002).
26. Akbarian, S. et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52, 258-266 (1995). The initial report of the now widely replicated deficit in GAD67 mRNA expression in the prefrontal cortex of individuals with schizophrenia.
27. 67 mRNA expression in a subset of prefrontal cortical γ-aminobutyric acid neurons in subjects with schizophrenia. Arch. Gen. Psychiatry 57, 237-245 (2000).
28. 67) expression in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 57, 1061-1069 (2000).
29. Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A. & Levitt, P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 53-67 (2000). This first application of microarray technology to the study of schizophrenia revealed altered expression of a group of genes that encode proteins involved in GABA neurotransmission in the prefrontal cortex of individuals with schizophrenia.
30. Vawter, M. P. et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 58, 11-20 (2002).
31. Hashimoto, T. et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J. Neurosci. 25, 372-383 (2005).
32. Knable, M. B., Barci, B. M., Bartko, J. J., Webster, M. J. & Torrey, E. F. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry 7, 392-404 (2002).
33. Benes, F. M., Todtenkopf, M. S., Logiotatos, P. & Williams, M. Glutamate decarboxy1ase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20, 259-269 (2000).
34. Asada, H. et al. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Comm. 229, 891-895 (1996).
35. Asada, H. et al. Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl Acad. Sci. USA 94, 6496-6499 (1997).
36. Markram, H. et al. Interneurons of the neocortical inhibitory system. Nature Rev. Neurosci. 5, 793-807 (2004). A comprehensive review of the various electrophysiological, morphological and molecular characteristics of GABA neurons in rodent cerebral cortex.
37. McBain, C. J. & Fisahn, A. Interneurons unbound. Nature Rev. Neurosci. 2, 11-23 (2001). An excellent review of the functional roles of GABA neurons in cortical function.
38. Lewis, D. A. & Lund, J. S. Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor and parvalbumin immunoreactive populations. J. Comp. Neurol. 293, 599-615 (1990).
39. Kawaguchi, Y. Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex. J. Neurosci. 15, 2638-2655 (1995). The first report that correlated electrophysiological and morphological features of cortical GABA neurons.
40. Somogyi, P. A specific axo-axonal interneuron in the visual cortex of the rat. Brain Res. 136, 345-350 (1977).
41. Condé. F., Lund, J. S., Jacobowitz, D. M., Baimbridge, K. G. & Lewis, D. A. Local circuit neurons immunoreactive for calretinin, calbindin D-28k, or parvalbumin in monkey prefrontal cortex: distribution and morphology. J. Comp. Neurol. 341, 95-116 (1994).
42. González-Burgos, G., Krimer, L. S., Povysheva, N. V., Barrionuevo, G. & Lewis, D. A. Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J. Neurophysiol. 93, 942-953 (2005).
43. Kawaguchi, Y. & Kubota, Y. Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience 85, 677-701 (1998).
44. Zaitsev A. V. et al. Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb. Cortex 8 December 2004 (doi:10.1093/cercor/bhh218).
45. Melchitzky, D. S., Eggan, S. M. & Lewis, D. A. Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience 130, 185-195 (2005).
46. Volk, D. W., Austin, M. C., Pierri, J. N., Sampson, A. R. & Lewis, D. A. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am. J. Psychiatry 158, 256-265 (2001).
47. Hashimoto, T. et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J. Neurosci. 23, 6315-6326 (2003). Through the use of subpopulation-specific molecular markers, this study confirmed that the parvalbumin-expressing subpopulation of GABA neurons is particularly vulnerable in schizophrenia.
48. Woo, T.-U., Miller, J. L. & Lews, D. A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am. J. Psychiatry 154, 1013-1015 (1997).
49. Beasley, C. L., Zhang, Z. J., Patten, I. & Reynolds, G. P. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins. Biol. Psychiatry 52, 708-715 (2002).
50. Woo, T.-U., Whitehead, R. E., Melchitzky, D. S. & Lewis, D. A. A subclass of prefrontal γ-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc. Natl Acad. Sci. USA 95, 5341-5346 (1998).
51. Pierri, J. N., Chaudry, A. S., Woo, T.-U. & Lewis, D. A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am. J. Psychiatry 156, 1709-1719 (1999).
52. A receptors.
53. A-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. Comp. Neurol. 359, 154-194 (1995).
54. Nusser, Z., Sieghart, W., Benke, D., Fritschy, J.-M. & Somogyi, P. Differential synaptic localization of two major γ-aminobutyric acid type A receptor α subunits on hippocampal pyramidal cells. Proc. Natl Acad. Sci. USA 93, 11939-11944 (1996).
55. A receptor subunits in the human brain. J. Histochem. Cytochem. 46, 1129-1139 (1998).
56. A receptor heterogeneity. Nature 335, 76-79 (1988).
57. A receptor channels are dependent on α-subunit isoform. Biophys. J. 73, 2518-2526 (1997).
58. A receptors in the axon initial segments of pyramidal neurons in individuals with schizophrenia.
59. Pierri, J. N., Volk, C. L., Auh, S., Sampson, A. & Lewis, D. A. Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations. Biol. Psychiatry 54, 111-120 (2003).
60. Cruz, D. A., Eggan, S. M., Azmitia, E. C. & Lewis, D. A. Serotonin1 A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia. Am. J. Psychiatry 161, 739-742 (2004).
61. B receptors in the hippocampus. J. Neurophysiol. 90, 2690-2701 (2003).
62. Erickson, S. L. & Lewis, D. A. Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J. Comp. Neurol. 448, 186-202 (2002).
63. Lewis, D. A., Cruz, D. A., Melchitzky, D. S. & Pierri, J. N. Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 158, 1411-1422 (2001).
64. 3H] Muscimol binding sites increased in autopsied brains of chronic schizophrenics. Life Sci. 40, 239-266 (1987).
65. A receptors in the prefrontal pyramidal neurons of individuals with schizophrenia.
66. A receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb. Cortex 5, 550-560 (1995).
67. Impagnatiello, F. et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl Acad. Sci. USA 35, 15718-15723 (1998).
68. A receptor α-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience 93, 441-448 (1999).
69. Benes, F. M., Kwok, E. W., Vincent, S. L. & Todtenkopf, M. S. Reduction of nonpyramidal cells in section CA2 of schizophrenics and manic depressives. Biol. Psychiatry 44, 88-97 (1998).
70. Heckers, S. et al. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59, 521-529 (2002).
71. Cotter, D. et al. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol. Psychiatry 51, 377-386 (2002).
72. Woo, T.-U., Walsh, J. P. & Benes, F. M. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch. Gen. Psychiatry 61, 649-657 (2004).
73. Konopaske, G. T., Sweet, R. A. & Lewis, D. A. GABA transporter-1 immunoreactivity in auditory association cortex in schizophrenia. Soc. Neurosci. Abstr. 34, 110.11 (2004).
74. Pesold, C. et al. Reelin is preferentially expressed in neurons synthesizing γ-aminobutyric acid in cortex and hippocampus of adult rats. Proc. Natl Acad. Sci. USA 95, 3221-3226 (1998).
75. Liu, W. S. et al. Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl Acad. Sci. USA 98, 3477-3482 (2001).
76. Resold, C., Liu, W. S., Guidotti, A., Costa, E. & Caruncho, H. J. Cortical bitufted, horizontal, and Martinotti cells preferentially express and secrete reelin in perineuronal nets, postsynapticaliy modulating gene expression. Proc. Natl Acad. Sci. USA 96, 3217-3222 (1999).
77. Dorph-Petersen, K.-A., Pierri, J. N., Sun, Z., Sampson, A. R. & Lewis, D. A. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. J. Comp. Neurol. 472, 449-462 (2004).
78. Volk, D. W. & Lewis, D. A. Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia. Biol. Psychiatry 53, 385-389 (2003).
79. Glantz, L. A. & Lewis, D. A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65-73 (2000).
80. Garey, L. J. et al. Reduced dendritic spine densfty on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry 65, 446-453 (1998).
81. Coyle, J. T., Tsai, G. & Goff, D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann. NY Acad. Sci. 1003, 318-327 (2003).
82. Morris, B. J., Cochran, S. M. & Pratt, J. A. PCP: from pharmacology to modelling schizophrenia. Curr. Opin. Pharmacol. 5, 101-106 (2005).
83. Bertolino, A. et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry 153, 1554-1563 (1996).
84. Lipska, B. K. & Weinberger, D. R. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 23, 223-239 (2000).
85. Lipska, B. K., Lerman, D. N., Khaing, Z. Z., Weickert, C. S. & Weinberger, D. R. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur. J. Neurosci. 18, 391-402 (2003).
86. 67), is associated with childhood-onset schizophrenia and cortical gray matter volume loss. Mol. Psychiatry 26 Oct 2004 (doi:10.1038/sj.mp.4001599).
87. Yamada, M. K. et al. Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. J. Neurosci. 22, 7580-7585 (2002).
88. Huang, Z. J. et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98, 739-755 (1999).
89. Cellerino, A., Maffei, L. & Domenici, L. The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin- containing neurons of the rat visual cortex. Eur. J. Neurosci. 8, 1190-1197 (1996).
90. Weickert, C. S. et al. Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia. Mol. Psychiatry 8, 592-610 (2003).
91. Thune, J. J., Uylings, H. B. M. & Pakkenberg, B. No deficit in total number of neurons in the prefrontal cortex in schizophrenics. J. Psychiatr. Res. 35, 15-21 (2001).
92. Xu, B. et al. The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. J. Neurosci. 20, 6888-6897 (2000).
93. Monteggia, J. M. et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc. Natl Acad. Sci. USA 101, 10827-10832 (2004).
94. Tallon-Baudry, C., Bertrand, O., Peronnet, F. & Pernier, J. Induced gamma-band activity during the delay of a visual short-term memory task in humans, J. Neurosci. 18, 4244-4254 (1998).
95. Howard, M. W. et al. Gamma oscillations correlate with working memory load in humans. Cereb Cortex 13, 1369-1374 (2003). Showed that gamma band power in the human prefrontal cortex increases directly with working memory load.
96. Spencer, K. M., Nestor, P. G., Salisbury, D. F., Shenton, M. E. & McCarley, R. W. Abnormal neural synchrony in schizophrenia. J. Neurosci. 23, 7407-7411 (2003).
97. Cho, R. Y., Konecky, R. O. & Carter, C. S. Impaired task-set maintenance and frontal cortical gamma-band synchrony in schizophrenia. Cognitive Neuroscience Society Annual Meeting (2004).
98. Cobb, S. R., Buhl, E. H., Halasy, K., Paulsen, O. & Somogyi, P. Synchronization of neuronal activity in hippocampus by indMdual GABAergic interneurons. Nature 378, 75-78 (1995). A seminal study that shows the crucial role of proximal inhibition in synchronizing pyramidal cell output.
99. Tamas, G., Buhl, E. H., Lorincz, A. & Somogyi, P. Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons. Nature Neurosci. 3, 366-371 (2000).
100. Blatow, M. et al. A novel network of multipolar bursting interneurons generates theta frequency oscillations in neocortex. Neuron 38, 805-817 (2003).
101. Peters, A. In Cerebral Cortex Vol. 1 (eds Jones, E. G. & Peters, A.) 361-380 (Plenum, New York. 1984).
102. Melchitzky, D. S., Sesack, S. R. & Lewis, D. A. Parvalbumin- immunoreactive axon terminals in macaque monkey and human prefrontal cortex; laminar, regional and target specificity of type I and type II synapses. J. Comp. Neurol. 408, 11-22 (1999).
103. Melchitzky, D. S., González-Burgos, G., Barrionuevo, G. & Lewis, D. A. Synaptic targets of the intrinsic axon collaterals of supragranular pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol. 430, 209-221 (2001).
104. Melchitzky, D. S. & Lewis, D. A. Pyramidal neuron local axon terminals in monkey prefrontal cortex: differential targeting of subclasses of GABA neurons, Cereb. Cortex 13, 452-460 (2003).
105. Pouille, F. & Scanziani, M. Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition. Science 293, 1159-1163 (2001). An important investigation that shows the role of feedforward perisomatic inhibition in controlling the timing of pyramidal cell function.
106. Vreugdenhil, M., Jefferys, J. G., Celio, M. R. & Schwaller, B. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J. Neurophysiol. 89, 1414-1422 (2003).
107. Overstreet, L. S. & Westbrook, G. L. Synapse density regulates independence at unitary inhibitory synapses. J. Neurosci. 23, 2618-2626 (2003).
108. Lews, D. A., Volk, D. W. & Hashimoto, T. Selective alterations in prefrontal cortical GABA neurotransmission in schcophrenia: a novel target for the treatment of working memory dysfunction. Psychopharmacology 174, 143-150 (2004).
109. Löw, K. et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290, 131-134 (2000).
110. Carpenter, W. T. Jr, Buchanan, R. W., Kirkpatrick, B. & Breier, A. F. Diazepam treatment of early signs of exacerbation in schfeophrenia. Am. J. Psychiatry 156, 299-303 (1999).
111. Winterer, G. & Weinberger, D. R. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci. 27, 683-690 (2004).
112. Moghaddam, B. Bringing order to the glutamate chaos in schizophrenia. Neuron 40, 881-884 (2003).
113. Sesack, S. R., Hawrylak, V. A., Melchitzky, D. S. & Lewis, D. A. Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb. Cortex 8, 614-622 (1998).
114. Kondo, M., Sumino, R. & Okado, H. Combinations of AMPA receptor subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins. J. Neurosci. 17, 1570-1581 (1997).
115. Spencer, K. M. et al. Neural synchrony indexes disordered perception and cognition in schizophrenia. Proc. Natl Acad. Sci. USA (2004).
116. Cruz, D. A., Eggan, S. M. & Lewis, D. A. Postnatal development of pre- and post-synaptic GABA markers at chandelier cell inputs to pyramidal neurons in monkey prefrontal cortex. J. Comp. Neurol. 465, 385-400 (2003).
117. Lund, J. S. & Lewis, D. A. Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J. Comp. Neurol. 328, 282-312 (1993).
118. Diamond, A. in Principles of Frontal Lobe Function (eds Stuss, D. T. & Knight, R. T.) 466-503 (Oxford Univ. Press, London, 2002).
119. Lewis, D. A., Glantz, L. A., Pierri, J. N. & Sweet, R. A. Altered cortical glutamate neurotransmission in schizophrenia: evidence from morphological studies of pyramidal neurons. Ann. NY Acad. Sci. 1003, 102-112 (2004).